Oncology Clinical Trials in Durham, NC

As of August 2026, 205 paid clinical trials are recruiting for Oncology in Durham, North Carolina. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

Newly added in Durham

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment

for Prostate Cancer

1 location in Durham

Sponsor: Duke University

Sex: Male·Age: 18+

Code: NCT07685249·Not Yet Recruiting·Listed Jul 6, 2026

ORASIS in Breast Reconstruction

for DIEP Flap

Sites in Durham & Raleigh

Sponsor: Duke University

Sex: Female·Age: 18+

Code: NCT07670754·Not Yet Recruiting·Listed Jun 2026

A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

for Advanced Solid Tumor

Sites in Durham +3 more locations

Sponsor: Clasp Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07650357·Phase 1·Not Yet Recruiting·Listed Jun 2026

Maximizing Quality of Life After Cancer Through Rehabilitation

for Head and Neck Cancer

Sites in Durham +2 more locations

Sponsor: VA Office of Research and Development

Sex: All·Age: 18 - 89

Code: NCT07622407·Not Yet Recruiting·Listed Jun 2026

209 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Durham, NC.

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for Urothelial Cancer

Drug: PF-08634404

Sites in Durham, Cary +131 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07421700·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for Intestinal Neoplasms

Drug: PF-08634404

Sites in Durham, Cary +198 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222800·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for Pancreatic Cancer

Drug: daraxonrasib

Sites in Durham +34 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07252232·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

for Carcinoma, Hepatocellular

Drug: PF-08634404

Sites in Durham, Cary +39 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07227012·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Sites in Durham, Chapel Hill +35 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Drug: Mevrometostat

Sites in Durham, Cary +122 more locations

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for Melanoma

Sites in Durham, Charlotte +89 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06246916·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

for Non-small Cell Lung Cancer

Drug: Zongertinib

Sites in Durham, Charlotte +25 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07195695·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for Breast Cancer

Sites in Durham, Greensboro +170 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for Endometrial Cancer

Sites in Durham +61 more locations

Sponsor: Genmab

Sex: Female·Age: 18+

Code: NCT07166094·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for Renal Cell Carcinoma (RCC)

Sites in Durham +43 more locations

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022

Apply to this trial

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for Large B-cell Lymphoma

Sites in Durham, Winston-Salem +34 more locations

Sponsor: Lyell Immunopharma, Inc.

Sex: All·Age: 18+

Code: NCT07188558·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for Colorectal Neoplasms

Sites in Durham, Pinehurst +106 more locations

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT05253651·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for Triple Negative Breast Cancer

Sites in Durham, Chapel Hill +122 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for Carcinoma, Non-Small-Cell Lung

Drug: LY3537982

Sites in Durham, Chapel Hill +86 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for Solid Tumors

Sites in Durham, Chapel Hill +40 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for Chronic Lymphocytic Leukemia

Sites in Durham, Chapel Hill +44 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06973187·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for Endometrial Cancer

Sites in Durham, Pinehurst +44 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06952504·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for Breast Cancer

Sites in Durham +58 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06790693·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for Neoplasms

Sites in Durham, Chapel Hill +76 more locations

Sponsor: Celgene

Sex: All·Age: All ages

Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018

Apply to this trial

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for Large B-cell Lymphoma

Sites in Durham, Charlotte +59 more locations

Sponsor: Allogene Therapeutics

Sex: All·Age: 18+

Code: NCT06500273·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for Breast Neoplasms

Sites in Durham +37 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06926868·Phase 2, Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

for Mantle Cell Lymphoma

Drug: Sonrotoclax

Sites in Durham, Winston-Salem +39 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06742996·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

for Pancreatic Ductal Adenocarcinoma

Sites in Durham +24 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06586515·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

for Prostate Cancer

Sites in Durham +20 more locations

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT04221542·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for Cancer

Sites in Durham +29 more locations

Sponsor: Parabilis Medicines, Inc.

Sex: All·Age: 18+

Code: NCT05919264·Phase 1, Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

for Metastatic Colorectal Cancer

Drug: Bevacizumab

Sites in Durham +10 more locations

Sponsor: Amgen

Sex: All·Age: 18+

Code: NCT06252649·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for Multiple Myeloma

Drug: Daratumumab

Sites in Durham, Winston-Salem +64 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05552222·Phase 3·Recruiting·Listed Sep 2022

Apply to this trial

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

for Colorectal Cancer

Sites in Durham +31 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT06445062·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for Myelofibrosis

Sites in Durham +29 more locations

Sponsor: Sumitomo Pharma America, Inc.

Sex: All·Age: 18+

Code: NCT04176198·Phase 1, Phase 2·Recruiting·Listed Nov 2019

Apply to this trial

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for Glioma

Sites in Durham +41 more locations

Sponsor: Nuvation Bio Inc.

Sex: All·Age: 18+

Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022

Apply to this trial

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

for Metastatic Breast Cancer

Sites in Durham +30 more locations

Sponsor: LeonaBio

Sex: All·Age: 18+

Code: NCT05696626·Phase 3·Recruiting·Listed Jan 2023

Apply to this trial

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for Non-Small Cell Lung Cancer

Drug: Ivonescimab

Sites in Durham, Chapel Hill +92 more locations

Sponsor: Summit Therapeutics

Sex: All·Age: 18+

Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for HER2 Mutation-Related Tumors

Sites in Durham +28 more locations

Sponsor: Iambic Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT06253871·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

for Prostate Cancer

Sites in Durham +26 more locations

Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male·Age: 18+

Code: NCT06056830·Phase 3·Recruiting·Listed Sep 2023

Apply to this trial

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for Leukemia, Myeloid, Acute

Sites in Durham, Chapel Hill +28 more locations

Sponsor: Sumitomo Pharma America, Inc.

Sex: All·Age: 12+

Code: NCT04988555·Phase 1, Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

GEMINI-NSCLC: NSCLC Biomarker Study

for Non-Small Cell Lung Cancer

Sites in Durham, Chapel Hill +54 more locations

Sponsor: Tempus AI

Sex: All·Age: 18+

Code: NCT05236114·Recruiting·Listed Feb 2022

Apply to this trial

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Durham +43 more locations

Sponsor: Kura Oncology, Inc.

Sex: All·Age: 18+

Code: NCT05735184·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for Advanced Solid Tumor

Sites in Durham +30 more locations

Sponsor: PMV Pharmaceuticals, Inc

Sex: All·Age: 12+

Code: NCT04585750·Phase 1, Phase 2·Recruiting·Listed Oct 2020

Apply to this trial

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for Epithelial Ovarian Cancer

Sites in Durham +25 more locations

Sponsor: TORL Biotherapeutics, LLC

Sex: Female·Age: 18+

Code: NCT06690775·Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

Top Research Study Locations in Durham

Researchers run research studies in Durham, NC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

Site	Specializes in	Active trials
Duke University Medical Center	Acute Myeloid Leukemia, Pulmonary Arterial Hypertension, Sickle Cell Disease	279
Duke University	Heart Failure, Prostate Cancer, Breast Cancer	199
Duke University Hospital	Heart Failure, Stroke, Traumatic Brain Injury	58
Duke University Health System	Diffuse Intrinsic Pontine Glioma, High Grade Glioma, WHO Grade III Glioma	46
Duke Cancer Institute	Breast Cancer, Advanced Solid Tumor, Cancer	39
Duke Cancer Center	Advanced Solid Tumor, Breast Cancer, Non-small Cell Lung Cancer	32
Durham VA Medical Center, Durham, NC	Tobacco Use Disorder, Cancer, Hearing Loss	32
Durham VA Medical Center	ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome	17
Duke University School of Medicine	Accidental Falls/Prevention and Control, Acquired Resistance to KRAS G12C Inhibitor, Acute Respiratory Failure	14
Duke Eye Center	Geographic Atrophy, Stargardt Disease, Age - Related Macular Degeneration (AMD)	12
Duke University Eye Center	Amblyopia, Retinal Disease, Eye Diseases	12
Duke Vaccine and Trials Unit	COVID -19, COVID-19 Infection, COVID-19 Vaccines	7
Duke University - Main Hospital and Clinics	Advanced Hepatocellular Carcinoma, COVID-19 Infection, Carcinoma, Hepatocellular	6
Clinical Trial Site	ATTR Amyloidosis, Cutaneous Sarcoidosis, Generalized Myasthenia Gravis	6
Duke Health	Breast Reconstruction, Cancer, Congestive Heart Failure Chronic	6
Duke University Medical Center - Duke Cancer Center	Advanced Solid Tumor, Cancer of the Prostate, Colorectal Cancer	6
GSK Investigational Site	Gastrointestinal Neoplasms, Colonic Neoplasms, HIV Infections	6
Duke Children's Hospital	Adamantinomatous Craniopharyngioma, Becker Muscular Dystrophy, Cardiomyopathy	5
Duke	Advanced Ovarian Carcinoma, Chronic Graft Versus Host Disease, Chronic Kidney Diseases	4
Duke Cancer Network	Advanced Breast Cancer, Advanced Colorectal Adenocarcinoma, Advanced Colorectal Carcinoma	4
Duke Children's Hospital & Health Center	Analgesics, Opioid, Congenital Heart Disease (CHD), Dravet Syndrome	4
Duke Lung Transplant Clinic - Clinic 2F/2G - PPDS	ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome	4
Duke Regional Hospital	Agitated Delirium, Atherosclerosis of Extremities, Delirium Confusional State	4
RTI International	Alcohol Misuse, Bystander Intervention, Community Reintegration	4
Duke Blood Cancer Center	AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent	3

Active & Upcoming Studies in Durham (2026)

Recruiting trials in Durham grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Common conditions studied in Durham

Heart Failure (20 active studies)
Breast Cancer (19 active studies)
Prostate Cancer (16 active studies)
Cancer (12 active studies)
Acute Myeloid Leukemia (11 active studies)
Stroke (11 active studies)

Leading research sponsors in Durham

Duke University
VA Office of Research and Development
National Cancer Institute (NCI)
AstraZeneca
Pfizer

Frequently asked questions

How many paid clinical trials are currently recruiting in Durham?

There are approximately 1,045 recruiting clinical trials in Durham, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Durham pay participants?

Most recruiting trials in Durham compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Durham?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Durham?

The most common conditions under active study in Durham include Heart Failure (20), Breast Cancer (19), Prostate Cancer (16), Cancer (12), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Durham?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Durham on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Durham?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Durham?

Recruiting research sites in Durham include Duke University Medical Center, Duke University, Duke University Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Durham right now?

The largest active categories in Durham are Cancer & tumors (286), Cardiovascular (95), Neurology & pain (67). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Other cities in North Carolina

Chapel Hill, NC(693)Winston-Salem, NC(530)Charlotte, NC(513)Raleigh, NC(182)Greenville, NC(154)Wilmington, NC(112)Greensboro, NC(107)Asheville, NC(87)Huntersville, NC(65)Cary, NC(60)Morehead City, NC(58)Pinehurst, NC(55)Monroe, NC(48)Fayetteville, NC(46)Jacksonville, NC(37)Statesville, NC(37)Gastonia, NC(33)Goldsboro, NC(32)Concord, NC(31)Salisbury, NC(30)Shelby, NC(30)Morrisville, NC(29)New Bern, NC(29)Clinton, NC(28)Hendersonville, NC(26)High Point, NC(25)Matthews, NC(25)Hillsborough, NC(21)Hickory, NC(20)Research Triangle Park, NC(19)Wake Forest, NC(18)Burlington, NC(16)Clemmons, NC(16)Wilson, NC(16)Kernersville, NC(15)Asheboro, NC(14)Reidsville, NC(14)Denver, NC(13)Kinston, NC(13)Mooresville, NC(13)Mount Airy, NC(13)Albemarle, NC(12)Forest City, NC(10)Kannapolis, NC(10)Rocky Mount, NC(10)Thomasville, NC(10)Lincolnton, NC(9)Leland, NC(8)Smithfield, NC(7)Clyde, NC(6)Fort Bragg, NC(6)North Wilkesboro, NC(6)Weaverville, NC(6)Carrboro, NC(5)Garner, NC(5)Lenoir, NC(5)Kings Mountain, NC(4)Wilkesboro, NC(4)Bermuda Run, NC(3)Fort Liberty, NC(3)

Related healthcare resources in North Carolina

Latest Durham, NC clinical trials research report

Trials by condition in Durham

Heart Failure· 20 Breast Cancer· 19 Prostate Cancer· 16 Acute Myeloid Leukemia· 11 Stroke· 11 Colorectal Cancer· 10

Conditions in Oncology (Durham, NC)

Solid tumor· 33 Breast cancer· 22 Cancer (any)· 20 Prostate cancer· 19 Non-small cell lung cancer (NSCLC)· 16 Colorectal cancer· 13 Pancreatic cancer· 11 Acute myeloid leukemia (AML)· 11 Ovarian cancer· 10 Multiple myeloma· 9 Chronic lymphocytic leukemia (CLL)· 9 Head and neck cancer· 9 Metastatic prostate cancer· 8 Endometrial cancer· 8 Glioblastoma· 8 Non-Hodgkin lymphoma· 8 Glioma· 7 Hematologic malignancy· 7 Metastatic breast cancer· 6 Melanoma· 6 Bladder cancer· 5 Myelodysplastic syndromes (MDS)· 5 Myelofibrosis· 5 Mantle cell lymphoma· 5 Triple-negative breast cancer· 4 Lung cancer· 4 Esophageal cancer· 4 Cervical cancer· 4 Diffuse large B-cell lymphoma (DLBCL)· 4 Follicular lymphoma· 4 Small lymphocytic lymphoma· 4 Sarcoma· 4 Neuroblastoma· 4 HER2-negative breast cancer· 3 Liver cancer· 3 Kidney cancer· 3 Acute lymphoblastic leukemia· 3 Leukemia (other)· 3 Osteosarcoma· 3 HER2-positive breast cancer· 2 Small cell lung cancer· 2 Gastric cancer· 2 Biliary tract cancer· 2 Fallopian tube cancer· 2 Chronic myelomonocytic leukemia· 2 Marginal zone lymphoma· 2 Thyroid cancer· 2 Metastatic colorectal cancer· 1 Colon cancer· 1 Gastroesophageal junction cancer· 1 Gastrointestinal cancer· 1 Uterine cancer· 1 Gynecologic cancer· 1 Brain metastases· 1 Myeloproliferative neoplasm· 1 Hodgkin lymphoma· 1 Burkitt lymphoma· 1 Soft tissue sarcoma· 1 Mesothelioma· 1

Oncology Clinical Trials in Durham, NC

Newly added in Durham

209 clinical trials for Oncology

Top Research Study Locations in Durham

Active & Upcoming Studies in Durham (2026)

Cancer & tumors (286 active studies)

Cardiovascular (95 active studies)

Neurology & pain (67 active studies)

Diabetes & metabolic (32 active studies)

Pediatric (26 active studies)

Mental health & behavior (22 active studies)

HIV / STI (13 active studies)

Eye & vision (11 active studies)

Vaccines (9 active studies)

Common conditions studied in Durham

Leading research sponsors in Durham

Frequently asked questions

How many paid clinical trials are currently recruiting in Durham?

Do clinical trials in Durham pay participants?

Who can participate in a clinical trial in Durham?

What conditions are most commonly studied in Durham?

Are there clinical trials for healthy volunteers in Durham?

How do I enroll in a clinical trial in Durham?

Where can I take part in paid clinical trials in Durham?

What kinds of studies are recruiting in Durham right now?

Browse more clinical trials

Other cities in North Carolina

Related healthcare resources in North Carolina

Trials by condition in Durham

Conditions in Oncology (Durham, NC)